The determination of cell size has been a common and useful parameter employed in the diagnosis of various haematological malignancies. The differentiation of acute lymphocytic leukaemia from acute myelogeneous leukaemia can be distinguished in part by cell size.' The classifications of lymphomas by Rappaport,2 Dorfman,3 and Lukes and Collins4 are based largely on the size of the cell. There have been studies5 6 attempting to correlate the size of neoplastic lymphoid cells with the prognosis of the patient. In some studies, the size of the cells was determined by measuring the cell diameters using an eyepice micrometer.5 This technique is tedious, and only large size differences may be accurately identified. In addition, the cell size may be artificially altered by drying, fixatives, dehydration and flattening of cells on glass surfaces.
Because of these limitations, automated and semiautomated systems for cell volume analysis have been Accepted for publication 27 April 1981 developed and the volume of many different cells in isotonic solutions has been determined.7-18 However, the volume of normal peripheral blood T and B lymphocytes, plastic adherent monocytes and a variety of neoplastic cells have not been well established using an automated system. The purpose of this report is to present our data regarding the size of normal T cells, B cells, and monocytes and neoplastic cells from a variety of malignant disorders using an electronic instrument system (Coulter Model H4 Channelyzer) which provides rapid unbiased volume measurements for thousands of cells.
Material and methods

SOURCES OF CELL POPULATIONS
Normal peripheral blood samples were obtained from 1084 leukaemia (CLL), acute lymphocytic leukaemia (ALL) and non-Hodgkin's lymphoma (NHL) were obtained with informed consent as part of routine diagnostic procedures, or during clinical follow-up visits.
The diagnosis of CLL was established in an adult patient when a persistent absolute lymphocytosis (>O15000/4l (>15 x 109/1)) was observed in association with a bone marrow aspirate containing over 50% mature lymphocytes without more than 5 % lymphoblasts.
The diagnosis of ALL was determined by the presence of lymphoblasts in the peripheral blood and lymphoblasts in the bone marrow (mean of 85 %).
The cytoplasm of the lymphoblasts was negative for the presence of peroxidase'9 and Sudan black B20 material but, was usually positive with the periodicacid Schiff (PAS) reagent.2'
The diagnosis of NHL was established on tissue biopsies according to the criteria and classification of Rappaport.2 FRACTIONATION OF CELLS Samples of venous blood (20 ml) were drawn into heparinised Vacutainer Tubes (Becton-Dickinson Co, Rutherford, NJ, 07070) or heparinised syringes, mixed, and promptly layered over 10 ml of Lymphocyte Separation Medium (LSM; 6-2 g Ficoll and 9-4 g sodium diatrizoate, Litton Bionetics, Inc, Kensington, Md., 20795) in a 50 ml centrifuge tube and spun for 30 min at 400 g. The LSM provided a gradient for isolation of the peripheral blood mononuclear (PBM) cells at the plasma/LSM interface. 22 The PBM cell layer was removed, and washed three times with 50 ml Hanks' balanced salt solution (HBSS; Gibco, Buffalo, NY, 14072) and then centrifuged for 10 min at 200 g. The washed PBM cells were resuspended at 5 x 106/ml in HBSS for sizing analysis, or further fractionated to give T cell, B cell, or monocyte enriched populations.
The procedure of Gmelig-Meyling and Ballieux23 permitted separation of PBM cells into populations of T lymphocytes and non-T cells on the basis of spontaneous rosette formation of T cells with sheep red blood cells (SRBC). PBM cells (1-5 x 107/ml concentration) and SRBC (15% suspension) were suspended in modified Eagles minimum essential medium (MEM; Gibco, Buffalo, NY, 14072). The MEM solution was prepared using 100 ml MEM with modified Earle's Salts, 3 ml of 34-5% bovine serum albumin and 3 ml of a I M HEPES solution. A total of 4 ml of the cell suspension and 1-5 ml of the SRBC suspension were mixed, overlayered on 4 ml LSM in 16 x 125 mm plastic tubes and immediately centrifuged at 1200 g for 30 min. The specified centrifugal speed must be reached within The size of lymphoblasts was determined in 20 cases of ALL (Table 1) . Samples were obtained from the bone marrow in 16 cases and from the peripheral blood in eight cases. In four cases, the samples were obtained from both bone marrow and peripheral blood. There was no significant difference between the size of lymphoblasts in the bone marrow and peripheral blood (p > 0-5). The average MCV of lymphoblasts from patients with ALL was 243 ± 58 ,um3 and the average modal volume was 219 ± 54 ,um3. The average MCV and modal volume of lymphoblasts from patients with ALL were larger than those of normal peripheral blood lymphocytes (p < 0-01). Within an individual ALL population, the lymphoblasts size demonstrated greater variability than observed in normal PBM cells (Table 1) as evidenced by a larger average standard deviation (Table 2 ). In Fig. 2 , the MCVs of normal and neoplastic cells were compared according to their lineage. Our study indicated that there was a great variation in cell size of lymphoblasts among and within cases of ALL. In addition, the data suggest that lymphoblasts from patients may cluster into at least two and perhaps three groups based on cell volume. We correlated cell size with the FAB classification of ALL35 and noted that the MCV of LI lymphoblasts was smaller than the MCV of L2 lymphoblasts but not at a significant level. The lack of significant correlation between MCV and the FAB classification is not unexpected since the FAB classification considers other criteria besides size of blasts. However, we hope to correlate the MCV of blasts with duration of first remission and survival of our patients with ALL.
Pantazopoulos and Sinks5 and Murphy et al.40 attempted to correlate lymphoblast size and prognosis in childhood ALL. In both studies a total of 200 lymphoblasts on stained bone marrow smears were measured using an eyepiece micrometer. Cells with a diameter less than 12 um were classified as microlymphoblasts. Pantazopoulos and Sinks5 found a better prognosis when macrolymphoblasts were 10 % or less of bone marrow cells in ALL patients. Murphy et al. 40 reported no relation between the percentage of macrolymphoblasts and response to treatment or survival. The small number of cells measured, the tedious method used, and the susceptibility of cells toward distortion on slide preparations may explain the contrasting results. In light of the much improved prognosis of childhood ALL in recent years, clinical studies combining the most successful protocols with standardised, automated cell volume analysis could resolve the question of lymphoblast size versus prognosis.
Cell volumes of normal and malignant mononuclear cells
The average MCVs of the non-Hodgkin's lymphomas corresponded moderately well with the histological classification proposed by Rappaport.2 The MCVs of lymphocytes from patients with PDLL was slightly larger than lymphocytes from lymph nodes with reactive hyperplasia and peripheral blood mononuclear cells. In addition, the current study demonstrated that lymphocytes from patients with HL and BL had the largest MCV and lymphocytes from patients with MHLL had an intermediate MCV. We are aware that these observations are based on a small sample and agree that further study is necessary to confirm our findings. In general the standard deviations within and among cases of NHL were considerably larger than in reactive lymph nodes and peripheral blood mononuclear cells from normal individuals indicating the tremendous heterogeneity of cell sizes in these lymphomas.
The MCVs of normal and neoplastic cells were compared according to the origin of these cells. The data suggested that, with the exception of cells from patients with CLL, neoplastic T and B lymphocytes were more heterogeneous and often larger than normal T and B lymphocytes.
To summarise, the current study demonstrated different MCVs among normal T lymphocytes, B lymphocytes and monocytes. Lymphocytes from patients with CLL were smaller than normal peripheral blood B lymphocytes and as a group showed no greater variation in size than normal B cells. In contrast, lymphoblasts from cases of ALL were larger than peripheral blood lymphocytes and showed considerable heterogeneity within and among individual cases. Lymphocytes from cases of NHL also demonstrated great variation in cell size within and among individual specimens. In general, there appeared to be an association between the MCVs of NHLs and the classification of lymphoma as proposed by Rappaport. We suggest that the sizing of cells from neoplastic lymphoproliferative disorders may be helpful in the future as a diagnostic and a prognostic procedure.
